“In the Know” features conversations with the people and personalities in biopharma.

Camille Samuels is one of just a smattering of female biopharma venture capitalists. But she doesn’t get too hung up on that fact: As a partner at Palo Alto’s Venrock and self-professed “math and science geek,” she prefers to focus solely on forging companies and making deals.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.